What is the management for an indeterminate Tuberculin Gold (TB Gold) result?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Indeterminate TB Gold Test Results

For patients with indeterminate QuantiFERON-TB Gold (QFT-G) test results, the optimal management approach is to repeat QFT-G testing with a newly obtained blood specimen or administer a tuberculin skin test (TST), with the decision based on the patient's risk factors for TB infection. 1

Understanding Indeterminate Results

Indeterminate QFT-G results provide no useful information regarding the likelihood of Mycobacterium tuberculosis infection. These results can occur due to:

  • High background levels of interferon-gamma in the nil sample
  • Inadequate response to mitogen (often associated with immunosuppression) 1, 2

Management Algorithm

Step 1: Identify Risk Factors for TB Infection

  • Recent contact with infectious TB cases
  • Birth or residence in high TB-incidence countries
  • Immunocompromised status
  • Abnormal chest radiograph consistent with prior TB
  • Age (very young or elderly patients have higher rates of indeterminate results) 3

Step 2: Determine Management Based on Risk Assessment

For High-Risk Individuals:

  • Repeat testing is recommended - either repeat QFT-G or administer TST 1, 2
  • Consider chest radiography to rule out active TB disease
  • If clinical suspicion for TB disease exists, proceed with additional diagnostic evaluations without delay:
    • Chest radiography
    • Bacteriologic studies
    • HIV testing 1

For Low-Risk Individuals:

  • No further testing is necessary after an indeterminate QFT-G result 1
  • Clinical monitoring may be appropriate

Step 3: Interpret Repeat Test Results

  • If repeat QFT-G is positive: Evaluate for TB disease before diagnosing latent TB infection (LTBI)
  • If repeat QFT-G is negative: No further evaluation needed in most cases
  • If repeat QFT-G remains indeterminate: Consider the pattern of indeterminate results
    • Persistently indeterminate results are often of the same type (low mitogen or high nil) 3

Special Considerations

Immunocompromised Patients

  • Indeterminate results due to inadequate mitogen response are more common in immunosuppressed individuals 2
  • Factors associated with indeterminate results include:
    • Corticosteroid use (adjusted OR 2.92) 4
    • Low albumin levels <3.5 g/dL (adjusted OR 3.62) 4
    • Elevated inflammatory markers (CRP, ESR) 5, 4
    • Advanced age 5

Hematological Factors

  • Abnormal white blood cell counts and lymphocyte percentages are predictors of indeterminate results in patients with hematological malignancies 6
  • Consider timing of QFT-G testing in relation to immunosuppressive therapy

Pitfalls to Avoid

  • Don't delay diagnostic evaluation for suspected TB disease while awaiting QFT-G results 1
  • Don't assume an indeterminate result rules out TB infection - it provides no useful information regarding infection status 1, 2
  • Don't ignore laboratory reports on the reason for indeterminate results (high nil vs. low mitogen) as this may guide clinical decision-making 1
  • Don't overlook technical factors - improper handling or processing of blood specimens can cause indeterminate results (blood must be incubated with test antigens within 12 hours of collection) 2

By following this structured approach to managing indeterminate QFT-G results, clinicians can make appropriate decisions regarding further testing and evaluation based on individual patient risk factors for TB infection.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnosis and Management of Latent Tuberculosis Infection

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Indeterminate QuantiFERON®-TB Gold results in a public health clinic setting.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2011

Research

Factors That Contribute to Indeterminate Results From the QuantiFERON-TB Gold In-Tube Test in Patients With Inflammatory Bowel Disease.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2018

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.